1Cockayne S, Adamson J, Lanham-New S, et al. (2006) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166, 1256–1261.
2Braam LAJLM, Knapen MH, Geusens P, et al. (2003) Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73, 21–26.
3Feskanich D, Weber P, Willett WC, et al. (1999) Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69, 74–79.
4Shearer MJ (2000) Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3, 433–438.
5Vermeer C, Shearer MJ, Zittermann A, et al. (2004) Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 43, 325–335.
6Wallin R, Sane DC & Hutson SM (2002) Vitamin K 2,3-epoxide reductase and the vitamin K-dependent γ-carboxylation system. Thromb Res 108, 221–226.
7Koshihara Y & Hoshi K (1997) Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12, 431–438.
8Binkley NC, Krueger DC, Engelke JA, et al. (2000) Vitamin K supplementation reduces serum concentrations of under-γ-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr 72, 1523–1528.
9Szulc P, Chapuy MC, Meunier PJ, et al. (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91, 1769–1774.
10Szulc P, Chapuy MC, Meunier PJ, et al. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18, 487–488.
11Vergnaud P, Garnero P, Meunier PJ, et al. (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82, 719–724.
12van Summeren MJH, Braam LAJLM, Noirt F, et al. (2007) Pronounced elevation of undercarboxylated osteocalcin in healthy children. Pediatr Res 61, 366–370.
13Sokoll LJ & Sadowski JA (1996) Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 63, 566–573.
14O'Connor E, Molgaard C, Michaelsen KF, et al. (2007) Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. Br J Nutr 97, 661–666.
15Van Summeren MJH, Van Coeverden SC, Schurgers LJ, et al. (2008) Vitamin K status is associated with childhood bone mineral content. Br J Nutr 100, 852–858.
16Binkley NC, Krueger DC, Kawahara TN, et al. (2002) A high phylloquinone intake is required to achieve maximal osteocalcin γ-carboxylation. Am J Clin Nutr 76, 1055–1060.
17Booth SL, Martini L, Peterson JW, et al. (2003) Dietary phylloquinone depletion and repletion in older women. J Nutr 133, 2565–2569.
18Schurgers LJ, Teunissen KJ, Hamulyak K, et al. (2006) Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 109, 3279–3283.
19Kalkwarf HJ, Khoury JC, Bean J, et al. (2004) Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 80, 1075–1080.
20Frederiks AM, van Buuren S, Burgmeijer RJF, et al. (1998) . In De Vierde Landelijke Groeistudie 1997. Presentatie Nieuwe Groeidiagrammen, Leiden: Bureau Boerhaave Commissie, Rijksuniversiteit Leiden.
21Schurgers LJ & Vermeer C (2000) Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 30, 298–307.
22Hemker H & Beguin S (1995) Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 74, 134–138.
23Nicolaidou P, Stavrinadis I, Loukou I, et al. (2006) The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 165, 540–545.
24Beker LT, Ahrens RA, Fink RJ, et al. (1997) Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 24, 512–517.
25Panis B, Vermeer C, van Kroonenburgh MJ, et al. (2006) Effect of calcium, vitamins K1 and D3 on bone in galactosemia. Bone 39, 1123–1129.
26Food and Nutrition Board (2001) . In Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, pp. 162–196. Washington, DC: National Academy Press.
27Collins A, Cashman KD & Kiely M (2006) Phylloquinone (vitamin K1) intakes and serum undercarboxylated osteocalcin levels in Irish postmenopausal women. Br J Nutr 95, 982–988.
28Knapen MHJ, Hamulyak K & Vermeer C (1989) The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 111, 1001–1005.
29Sokoll LJ, Booth SL, O'Brien ME, et al. (1997) Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 65, 779–784.
30Lee NK, Sowa H, Hinoi E, et al. (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456–469.
31Price PA, Williamson MK & Lothringer JW (1981) Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 256, 12760–12766.
32Shearer MJ & Newman P (2008) Metabolism and cell biology of vitamin K. Thromb Haemost 100, 530–547.
33Tabb MM, Sun A, Zhou C, et al. (2003) Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor, SXR. J Biol Chem 278, 43919–43927.
34Katsuyama H, Otsuki T, Tomita M, et al. (2005) Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med 15, 231–236.
35Yamaguchi M, Kakuda H, Gao YH, et al. (2000) Prolonged intake of fermented soybean (natto) diets containing vitamin K2 (menaquinone-7) prevents bone loss in ovariectomized rats. J Bone Miner Metab 18, 71–76.
36Yamaguchi M, Taguchi H, Gao YH, et al. (1999) Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab 17, 23–29.